Structured Benefit-Risk Assessment of a New Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Individuals Ages 12 Months and Older

Prevention of Meningococcal Infection in the United States: Current Recommendations and Future Considerations - ScienceDirect

PDF) 1243. Semi-Quantitative Benefit-Risk Assessment for a New Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Individuals 2 Years of Age and Older

An evaluation of emerging vaccines for childhood meningococcal disease, BMC Public Health

Meningococcal Vaccine: Most Up-to-Date Encyclopedia, News & Reviews

Meningococcal Serogroup ACWYX Conjugate Vaccine in Malian Toddlers

A Decade of Fighting Invasive Meningococcal Disease: A Narrative Review of Clinical and Real-World Experience with the MenACWY-CRM Conjugate Vaccine

Frontiers Trends in Adult and Elderly Vaccination: Focus on Vaccination Practices in Tunisia and Morocco

Pathogens, Free Full-Text

Meningococcal Serogroup ACWYX Conjugate Vaccine in Malian Toddlers

hSBA vaccine seroresponse a after a booster dose of MenACYW-TT at (a)

A Phase II, randomized, immunogenicity and safety study of a quadrivalent meningococcal conjugate vaccine, MenACYW-TT, in healthy adolescents in the United States - ScienceDirect

Vaccines, Free Full-Text

Immunogenicity and Safety of a Meningococcal A Conjugate Vaccine in Africans

An evaluation of emerging vaccines for childhood meningococcal disease – topic of research paper in Economics and business. Download scholarly article PDF and read for free on CyberLeninka open science hub.

Development of a New Solid-Phase Extraction Base Method for Free Saccharide Content Estimation of Meningococcal Conjugate Vaccines